2024 Regulatory Approvals Across NSCLC Propel the Therapeutic Landscape Forward
Noman Ashraf, MD, discusses the evolving treatment landscape in non–small cell lung cancer following numerous regulatory approvals in the space.
Noman Ashraf, MD, discusses the evolving treatment landscape in non–small cell lung cancer following numerous regulatory approvals in the space.
This study explored the safety and efficacy of a CXCR2 agonist and plerixafor for mobilization of HSCs for hematopoietic stem cell transplantation in patients with…
In the latest installment of the “How Do I?” insurance series, Bethany Lilly, the Executive Director of Public Policy at The Leukemia & Lymphoma Society,…
Xiaojia Wang, MD, discusses findings for ivonescimab plus chemotherapy in metastatic triple-negative breast cancer.
Mouse study of therapeutic food for malnourished children reveals new gut bacterial enzyme’s wide-ranging functions
An abstract is unavailable.
A list of current APEx®facilities.
A new initiative to rapidly place individuals with acute myeloid leukemia or myelodysplastic syndrome in clinical trials based on their genomic profiles has opened in…
Sung Gwe Ahn, MD, PhD, discusses survival outcomes with ovarian function suppression-based endocrine therapy based on the HERA trial in HR-positive, HER2-positive breast cancer.
Overview for AACR Special Conference in Cancer Research: Functional and Genomic Precision Medicine in Cancer: Different Perspectives, Common Goals
We examine the context and explore some of the tools Elsevier has developed to counter the increasing threat of unethical behavior